MiRNA expression in urothelial carcinomas: important roles of miR-10a, miR-222, miR-125b, miR-7 and miR-452 for tumor stage and metastasis, and frequent homozygous losses of miR-31 - PubMed (original) (raw)
. 2009 May 1;124(9):2236-42.
doi: 10.1002/ijc.24183.
David Lindgren, Anders Kvist, Attila Frigyesi, Johan Staaf, Helena Persson, Fredrik Liedberg, Gunilla Chebil, Sigurdur Gudjonsson, Ake Borg, Wiking Månsson, Carlos Rovira, Mattias Höglund
Affiliations
- PMID: 19127597
- DOI: 10.1002/ijc.24183
MiRNA expression in urothelial carcinomas: important roles of miR-10a, miR-222, miR-125b, miR-7 and miR-452 for tumor stage and metastasis, and frequent homozygous losses of miR-31
Srinivas Veerla et al. Int J Cancer. 2009.
Abstract
We analyzed 34 cases of urothelial carcinomas by miRNA, mRNA and genomic profiling. Unsupervised hierarchical clustering using expression information for 300 miRNAs produced 3 major clusters of tumors corresponding to Ta, T1 and T2-T3 tumors, respectively. A subsequent SAM analysis identified 51 miRNAs that discriminated the 3 pathological subtypes. A score based on the expression levels of the 51 miRNAs, identified muscle invasive tumors with high precision and sensitivity. MiRNAs showing high expression in muscle invasive tumors included miR-222 and miR-125b and in Ta tumors miR-10a. A miRNA signature for FGFR3 mutated cases was also identified with miR-7 as an important member. MiR-31, located in 9p21, was found to be homozygously deleted in 3 cases and miR-452 and miR-452* were shown to be over expressed in node positive tumors. In addition, these latter miRNAs were shown to be excellent prognostic markers for death by disease as outcome. The presented data shows that pathological subtypes of urothelial carcinoma show distinct miRNA gene expression signatures.
(c) 2008 Wiley-Liss, Inc.
Similar articles
- microRNA expression profile in a large series of bladder tumors: identification of a 3-miRNA signature associated with aggressiveness of muscle-invasive bladder cancer.
Pignot G, Cizeron-Clairac G, Vacher S, Susini A, Tozlu S, Vieillefond A, Zerbib M, Lidereau R, Debre B, Amsellem-Ouazana D, Bieche I. Pignot G, et al. Int J Cancer. 2013 Jun 1;132(11):2479-91. doi: 10.1002/ijc.27949. Epub 2013 Feb 25. Int J Cancer. 2013. PMID: 23169479 - Stage, grade and behavior of bladder urothelial carcinoma defined by the microRNA expression profile.
Dip N, Reis ST, Timoszczuk LS, Viana NI, Piantino CB, Morais DR, Moura CM, Abe DK, Silva IA, Srougi M, Dall'Oglio MF, Leite KR. Dip N, et al. J Urol. 2012 Nov;188(5):1951-6. doi: 10.1016/j.juro.2012.07.004. Epub 2012 Sep 20. J Urol. 2012. PMID: 22999546 - A MicroRNA expression profile defining the invasive bladder tumor phenotype.
Wszolek MF, Rieger-Christ KM, Kenney PA, Gould JJ, Silva Neto B, Lavoie AK, Logvinenko T, Libertino JA, Summerhayes IC. Wszolek MF, et al. Urol Oncol. 2011 Nov-Dec;29(6):794-801.e1. doi: 10.1016/j.urolonc.2009.08.024. Epub 2009 Nov 27. Urol Oncol. 2011. PMID: 19945312 - Prognostic value of microRNA expression pattern in upper tract urothelial carcinoma.
Izquierdo L, Ingelmo-Torres M, Mallofré C, Lozano JJ, Verhasselt-Crinquette M, Leroy X, Colin P, Comperat E, Roupret M, Alcaraz A, Mengual L. Izquierdo L, et al. BJU Int. 2014 May;113(5):813-21. doi: 10.1111/bju.12551. BJU Int. 2014. PMID: 24180461 Review. - Clinical and pathological implications of miRNA in bladder cancer.
Braicu C, Cojocneanu-Petric R, Chira S, Truta A, Floares A, Petrut B, Achimas-Cadariu P, Berindan-Neagoe I. Braicu C, et al. Int J Nanomedicine. 2015 Jan 20;10:791-800. doi: 10.2147/IJN.S72904. eCollection 2015. Int J Nanomedicine. 2015. PMID: 25653521 Free PMC article. Review.
Cited by
- Pivotal MicroRNAs in Melanoma: A Mini-Review.
Deng Z, Hao J, Lei D, He Y, Lu L, He L. Deng Z, et al. Mol Diagn Ther. 2016 Oct;20(5):449-55. doi: 10.1007/s40291-016-0219-y. Mol Diagn Ther. 2016. PMID: 27351922 Review. - MiR-31 and miR-128 regulates poliovirus receptor-related 4 mediated measles virus infectivity in tumors.
Geekiyanage H, Galanis E. Geekiyanage H, et al. Mol Oncol. 2016 Nov;10(9):1387-1403. doi: 10.1016/j.molonc.2016.07.007. Epub 2016 Jul 28. Mol Oncol. 2016. PMID: 27507538 Free PMC article. - Diagnostic, prognostic and therapeutic implications of microRNAs in urologic tumors.
Schaefer A, Stephan C, Busch J, Yousef GM, Jung K. Schaefer A, et al. Nat Rev Urol. 2010 May;7(5):286-97. doi: 10.1038/nrurol.2010.45. Epub 2010 Apr 6. Nat Rev Urol. 2010. PMID: 20368743 Review. - MicroRNA-452: a double-edged sword in multiple human cancers.
Karimi Dermani F, Datta I, Gholamzadeh Khoei S. Karimi Dermani F, et al. Clin Transl Oncol. 2023 May;25(5):1189-1206. doi: 10.1007/s12094-022-03041-0. Epub 2023 Jan 9. Clin Transl Oncol. 2023. PMID: 36622551 Review. - MiRNA expression profile and miRNA-mRNA integrated analysis (MMIA) during podocyte differentiation.
Li Z, Wang L, Xu J, Yang Z. Li Z, et al. Mol Genet Genomics. 2015 Jun;290(3):863-75. doi: 10.1007/s00438-014-0960-z. Epub 2014 Nov 30. Mol Genet Genomics. 2015. PMID: 25433550
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical